While the trial showed a numerical trend toward improvement in hyperphagia questionnaire for clinical trials (HQ-CT) total scores at week 13, the difference vs placebo did not reach statistical significance [ 13 ].
← all excerpts
Diazoxide choline extended-release (DCCR) use in Prader-Willi syndrome: patient selection, dosing, and management.
2
—
—
The sentences
While the trial showed a numerical trend toward improvement in hyperphagia questionnaire for clinical trials (HQ-CT) total scores at week 13, the difference vs placebo did not reach statistical significance [ 13 ].